Biofrontera Inc. (BFRI) Financials
BFRI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 24.1 million | 18.1 million |
| March 31, 2026 | 24.8 million | 18.7 million |
| Dec. 31, 2025 | 28.6 million | 18.1 million |
| Sept. 30, 2025 | 15.4 million | 18.0 million |
BFRI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -1.7 million | 263000 |
| March 31, 2026 | -75000 | 342000 |
| Dec. 31, 2025 | -2.4 million | 289000 |
| Sept. 30, 2025 | -3.8 million | 236000 |
BFRI Net Income
No data available :(
BFRI Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 4.7 million | 4.6 million | 2.9 million |
| March 31, 2026 | 6.3 million | 7.2 million | 506000 |
| Dec. 31, 2025 | 6.4 million | 5.8 million | 332000 |
| Sept. 30, 2025 | 3.4 million | 4.6 million | 443000 |
BFRI Shares Outstanding
BFRI Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 448000 | 9.7 million | - |
| March 31, 2026 | 5000 | 900000 | 11.0 million | - |
| Dec. 31, 2025 | 1000 | 787000 | 8.7 million | - |
| Sept. 30, 2025 | 1000 | 837000 | 10.4 million | - |
BFRI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 12.0 million | 2.4 million |
| March 31, 2026 | 10.1 million | 1.8 million |
| Dec. 31, 2025 | 17.1 million | 871000 |
| Sept. 30, 2025 | 7.0 million | 2.1 million |
BFRI Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BFRI
Price: $0.93
52 week price:
Earnings Per Share: -0.43 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 345400
Market Capitalization: 11.9 million